<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beyhoff N</submitter><funding>Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.</funding><funding>Deutsches Zentrum für Herz-Kreislaufforschung</funding><funding>Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung</funding><pagination>3411-3422</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12803576</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(12)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Perturbations of myocardial metabolism and energy depletion are well-established hallmarks of heart failure (HF), yet methods for their systematic assessment remain limited in humans. This study aimed to determine the ability of computational modelling of patient-specific myocardial metabolism to assess individual bioenergetic phenotypes and their clinical implications in HF.&lt;h4>Methods and results&lt;/h4>Based on proteomics-derived enzyme quantities in 136 cardiac biopsies, personalised computational models of myocardial metabolism were generated in two independent cohorts of advanced HF patients together with sex- and body mass index-matched non-failing controls. The bioenergetic impact of dynamic changes in substrate availability and myocardial workload were simulated, and the</pubmed_abstract><journal>European journal of heart failure</journal><pubmed_title>Computational modelling of myocardial metabolism in patients with advanced heart failure.</pubmed_title><pmcid>PMC12803576</pmcid><funding_grant_id>DGK07/2021</funding_grant_id><funding_grant_id>81Z0100212</funding_grant_id><pubmed_authors>Baczko I</pubmed_authors><pubmed_authors>Kintscher U</pubmed_authors><pubmed_authors>Neubauer S</pubmed_authors><pubmed_authors>Holzhutter HG</pubmed_authors><pubmed_authors>Potapov E</pubmed_authors><pubmed_authors>Knosalla C</pubmed_authors><pubmed_authors>Kuehne T</pubmed_authors><pubmed_authors>Braun VM</pubmed_authors><pubmed_authors>Tyler DJ</pubmed_authors><pubmed_authors>Grune T</pubmed_authors><pubmed_authors>Kirchner M</pubmed_authors><pubmed_authors>Finnigan LEM</pubmed_authors><pubmed_authors>Berndt N</pubmed_authors><pubmed_authors>Rider OJ</pubmed_authors><pubmed_authors>Milting H</pubmed_authors><pubmed_authors>Beyhoff N</pubmed_authors><pubmed_authors>Mertins P</pubmed_authors><pubmed_authors>Raman B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational modelling of myocardial metabolism in patients with advanced heart failure.</name><description>&lt;h4>Aims&lt;/h4>Perturbations of myocardial metabolism and energy depletion are well-established hallmarks of heart failure (HF), yet methods for their systematic assessment remain limited in humans. This study aimed to determine the ability of computational modelling of patient-specific myocardial metabolism to assess individual bioenergetic phenotypes and their clinical implications in HF.&lt;h4>Methods and results&lt;/h4>Based on proteomics-derived enzyme quantities in 136 cardiac biopsies, personalised computational models of myocardial metabolism were generated in two independent cohorts of advanced HF patients together with sex- and body mass index-matched non-failing controls. The bioenergetic impact of dynamic changes in substrate availability and myocardial workload were simulated, and the</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-07-15T13:19:47.376Z</modification><creation>2026-07-05T03:08:37.787Z</creation></dates><accession>S-EPMC12803576</accession><cross_references><pubmed>40662214</pubmed><doi>10.1002/ejhf.3746</doi></cross_references></HashMap>